Digistain

DigiStain – The UK’s First Breast Cancer
Risk Profiling Technology

A Digital Solution To Cancer Grading And Prognosis approved by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA), Digistain is a patented risk profiling test for hormone receptor-positive breast cancer patients.

www.digistain.co.uk